acyclovir
Generic: acyclovir
Labeler: proficient rx lpDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
proficient rx lp
Dosage Form
CAPSULE
Routes
Active Ingredients
acyclovir 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71205-578
Product ID
71205-578_e95e1c62-32d4-46b8-ab0f-c662b837f9b8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206261
Listing Expiration
2026-12-31
Marketing Start
2017-08-17
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71205578
Hyphenated Format
71205-578
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA206261 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE, PLASTIC (71205-578-30)
- 60 CAPSULE in 1 BOTTLE, PLASTIC (71205-578-60)
- 90 CAPSULE in 1 BOTTLE, PLASTIC (71205-578-90)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e95e1c62-32d4-46b8-ab0f-c662b837f9b8", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0371205578909"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["e8056ec6-d2dc-48af-8550-82726af1c5c5"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (71205-578-30)", "package_ndc": "71205-578-30", "marketing_start_date": "20210610"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE, PLASTIC (71205-578-60)", "package_ndc": "71205-578-60", "marketing_start_date": "20210610"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE, PLASTIC (71205-578-90)", "package_ndc": "71205-578-90", "marketing_start_date": "20210610"}], "brand_name": "Acyclovir", "product_id": "71205-578_e95e1c62-32d4-46b8-ab0f-c662b837f9b8", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71205-578", "generic_name": "Acyclovir", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA206261", "marketing_category": "ANDA", "marketing_start_date": "20170817", "listing_expiration_date": "20261231"}